International Journal of Pharmaceutical Research and Nanotechnology

Authors: Mohammad Emon, Sanjida Khatun

Abstract: Nanoparticle-based drug delivery systems (NDDS) have emerged as a promising approach to improve the efficacy of cancer therapy. By enhancing the bioavailability and specificity of therapeutic agents, nanoparticles can target cancer cells with high precision while minimizing the systemic side effects associated with conventional chemotherapy. This paper discusses the various types of nanoparticles used in drug delivery systems, including liposomes, dendrimers, micelles, and solid lipid nanoparticles. It also explores the mechanisms of targeted drug delivery, the challenges in nanoparticle design, and the future perspectives in clinical applications for cancer therapy. Through a comprehensive review of the literature, we examine how these systems can revolutionize cancer treatment, focusing on recent advancements and their potential to provide better clinical outcomes.

Keywords: Nanoparticles, Drug Delivery, Targeted Therapy, Cancer, Liposomes, Dendrimers, Micelles, Bioavailability, Cancer Treatment